PRKN and neoplasm: More particularly, elimination of defective mitochondria and tumor suppression are mediated via the PINK1/PARK2 pathway, in which PRKN/PARK2 is transformed into E3 ligase that ubiquitinates the impaired mitochondrial proteins [74,75].